Insider Transactions in Q4 2021 at Mirati Therapeutics, Inc. (MRTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2021
|
Jamie Christensen EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,149
+19.56%
|
-
|
|
Dec 16
2021
|
Charles M Baum Founder, President, and CEO |
SELL
Bona fide gift
|
Direct |
7,430
-6.59%
|
-
|
|
Dec 06
2021
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,201
-0.99%
|
$157,331
$131.39 P/Share
|
|
Dec 03
2021
|
Jamie Christensen EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,856
+10.15%
|
-
|
|
Dec 03
2021
|
Charles M Baum Founder, President, and CEO |
SELL
Open market or private sale
|
Direct |
47,204
-4.78%
|
$6,325,336
$134.54 P/Share
|
|
Dec 03
2021
|
Charles M Baum Founder, President, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,204
+22.79%
|
$377,632
$8.49 P/Share
|